Fenwick & West represented Agilent Technologies (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, in its underwritten public offering of $300,000,000 aggregate principal amount of senior notes due 2026. The offering was made pursuant to an effective shelf registration statement previously filed with the SEC.
BNP Paribas Securities Corp., Citigroup Global Markets Inc. and Credit Suisse Securities (USA) LLC acted as representatives for the underwriters, which also included Barclays Capital Inc., HSBC Securities (USA) Inc., Lloyds Securities Inc. and Wells Fargo Securities LLC.
The Fenwick transaction team included corporate partner David Michaels and associates Ran Ben-Tzur, Jennifer Hitchcock and Amanda Baratz.